GlassScriptPhysician profile
Anita Bernhard
NPI 1306108980
$2,951.39
in general payments reported to CMS, 2019-2025
38 companies · $446 in 2025
The $446 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $373 · 2021: $648 · 2022: $355 · 2023: $500 · 2024: $264 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $327.58 | 2019-2025 | Acessa Provu System, Aptima, Myosure Tissue Removal Device |
| Abbvie INC. | $279.23 | 2020-2023 | Lo Loestrin Fe |
| Therapeuticsmd, INC. | $221.42 | 2019-2021 | |
| Organon LLC | $192.90 | 2021-2025 | Nexplanon, Jada System |
| Millicent US INC | $172.59 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Mayne Pharma Commercial LLC | $165.65 | 2021-2025 | |
| Exeltis, USA INC. | $159.54 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $145.52 | 2019-2025 | Paragard T 380a |
| Daiichi Sankyo INC. | $132.19 | 2019-2025 | Datroway, Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $125.39 | 2019-2025 | |
| Intuitive Surgical, INC. | $107.36 | 2020 | |
| Merck Sharp & Dohme LLC | $105.40 | 2019-2021 | |
| Lupin INC. | $58.88 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $58.80 | 2020-2022 | |
| Avion Pharmaceuticals | $57.22 | 2020-2023 | Balcoltra |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $56.77 | 2025 | Zurzuvae |
| Incyte Corporation | $49.91 | 2025 | Jakafi, Zynyz, Monjuvi |
| Amgen INC. | $45.59 | 2021-2023 | Prolia, Evenity |
| Agile Therapeutics, INC. | $45.06 | 2023 | Twirla |
| Roche Diagnostics Corporation | $42.87 | 2019 | |
| Astellas Pharma US INC | $38.68 | 2025 | Veozah |
| Ethicon US, LLC | $35.90 | 2019-2021 | |
| Minerva Surgical, INC | $33.17 | 2019-2024 | |
| Pfizer INC. | $31.54 | 2020-2021 | |
| Gynesonics, INC. | $30.29 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $30.06 | 2023 | Exparel |
| Boston Scientific Corporation | $27.58 | 2019 | |
| Sobi, INC | $23.92 | 2025 | |
| Exact Sciences Corporation | $18.61 | 2025 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $18.19 | 2019 | |
| Evofem Biosciences, INC. | $16.07 | 2020 | |
| Becton, Dickinson and Company | $16.07 | 2021 | |
| Sage Therapeutics, LLC | $15.83 | 2022 | |
| Olympus America INC. | $14.82 | 2024 | Olympus |
| Seqirus USA INC | $14.68 | 2024 | Flucelvax, Fluad |
| Shield Therapeutics INC | $12.79 | 2022 | |
| Forte Bio-Pharma LLC | $11.74 | 2019 | |
| Duchesnay USA Incorporated | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Bernhard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.